NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

Spot on Flipper. Most of the space has been left open for rapid expansion of Flaskworks once approved.
One of the biggest bullish signals was when the company announced the start of manufacturing of specials for a single patient. Some shorts may have taken this lack of patients as a negative sign but for me this indicates how close we are to the point where patients in the UK will be able to get reimbursement from the NHS.
Something is brewing and I believe Dr Ashkan and the many patients awaiting DVAX-L are in the wings ready to receive treatment as soon as the floodgates are open through TLD/Journal and quick approval in the UK.